Daniel Adu‐Ampratwum

Daniel Adu-Ampratwum's research centers on medicinal chemistry approaches to fighting HIV, particularly studying how the antiviral drug lenacapavir interacts with and can be modified to overcome drug-resistant forms of the HIV-1 capsid (the protein shell that protects the virus's genetic material). Earlier work also involved synthesizing complex natural products from marine sponges and toxins, reflecting a background in organic synthesis. The work combines structural biology, chemical synthesis, and drug design to address treatment challenges in infectious disease.

Publication output has been irregular over the past decade with gaps in some years, but has increased notably in 2024-2025 after a period of low activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026